BDNF -270 C>T polymorphisms might be associated with stroke type and BDNF -196 G>A corresponds to early neurological deficit in hemorrhagic stroke

Journal of Neuroimmunology

Volumn 249, Issue 1-2, 2012, Pages 71-75

  Mirowska Guzel, Dagmara ^a,b   Gromadzka, Grazyna ^a,b   Czlonkowski, Andrzej ^a   Czlonkowska, Anna ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

BDNF; Clinical outcome; Neurological deficit; Polymorphism; Stroke

Indexed keywords

ADENINE; CYTOSINE; GUANINE; THYMINE;

AGED; ARTICLE; BDNF GENE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HETEROZYGOTE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

AGED; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RECOVERY OF FUNCTION; STROKE;

EID: 84863476200     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.04.011     Document Type: Article

References (39)

1. Ali M., Lyden P., Sacco R.L., Shuaib A., Lees K.R. Natural history of complications after intracerebral hemorrhage. Eur. J. Neurol. 2009, 16:624-630. VISTA investigators.
2. Aslanyan S., Weir C.J., Diener H.C., Kaste M., Lees K.R. Pneumonia and urinary tract infection after acute ischemic stroke: a tertiary analysis of the GAIN International trial. Eur. J. Neurol. 2004, 11:49-53. GAIN International Steering Committee and Investigators.
3. Bath K.G., Lee F.S. Variant BDNF (Val66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci. 2006, 6:79-85.
4. Bonita R. Epidemiology of stroke. Lancet 1992, 339:342-344.
5. Brott T., Adams H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., Spilker J., Holleran R., Eberle R., Hertzberg V., Rorick M., Moomaw C.J., Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-870.
6. Cerasa A., Tongiorgi E., Fera F., Gioia M.C., Valentino P., Liguori M., Manna I., Zito G., Passamonti L., Nistico R., Quattrone A. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav. Brain Res. 2010, 207:377-386.
7. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 2004, 24:4401-4411.
8. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolchana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
9. Emsley H.C.A., Hopkins S.J. Acute ischemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008, 7:341-353.
10. Foulkes M., Wolf P., Proce T. Stroke Data Bank: design, methods, and baseline characteristic. Stroke 1988, 19:547-554.
11. Gao L., Diaz-Corrales F.J., Carrillo F., Diaz-Martin J., Caceres-Redondo M.T., Carballo M., Palomino A., Lopez-Barneo J., Mir P. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease. Acta Neurol. Scand. 2010, 122:41-45.
12. Goldstein L.B., Bartels C., Davis J.N. Interrater reliability of the NIH stroke scale. Arch. Neurol. 1989, 46:660-662.
13. Grabska K., Gromadzka G., Czlonkowska A. Infections and ischemic stroke outcome. Neurol. Res. Int. 2011, 691348:1-8. (ID).
14. Gustafsson E., Andsberg G., Darsalia V., Mohapel P., Mandel R.J., Kirik D., Lindvall O., Kokaia Z. Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke. Eur. J. Neurosci. 2003, 17:2667-2678.
15. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
16. Kwan J., Hand P. Infection after acute stroke is associated with poor short-term outcome. Acta Neurol. Scand. 2007, 115:331-338.
17. Laske C., Stansky E., Leyhe T., Eschweiler G.W., Wittorf A., Richartz E., Bartels M., Buchkremer G., Schott K. Stage-dependent BDNF serum concentration in Alzheimer's disease. J. Neural Transm. 2006, 113:1217-1224.
18. Lee H.M., Lim I.J., Lee M.C., Kim S.U. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J. Neurosci. Res. 2010, 88:3282-3294.
19. Mahoney F.I., Barthel D. Functional evaluation: the Barthel Index. Md. State Med. J. 1965, 14:56-61.
20. Maisonpierre P.C., Le Beau M.M., Espinosa R. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions and chromosomal localizations. Genomics 1991, 10:558-568.
21. Mirowska-Guzel D., Mach A., Gromadzka G., Czlonkowski A., Czlonkowska A. G196A and C720T BDNF gene polymorphisms and susceptibility to multiple sclerosis. J. Neuroimmunol. 2008, 193:170-172.
22. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from family-based association study. Am. J. Hum. Genet. 2002, 71:651-655.
23. Nygren J., Kokaia M., Wieloch T. Decreased expression of brain-derived neurotrophic factor in BDNF(+/-) mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental stroke. J. Neurosci. Res. 2006, 84:626-631.
24. O'Brien E.C., Rose K.M., Shahar E., Rosamond W.D. Stroke mortality, clinical presentation and day of arrival: the atherosclerosis risk in community (AIRC) study. Stroke Res. Treat. 2011, ID383012:1-8.
25. Ozan E., Okur H., Eker C., Eker O.D., Akarsu N. The effect of depression, BDNF gene polymorphism and gender on serum BDNF levels. Brain Res. Bull. 2010, 81:61-65.
26. Petryshern T.L., Sabeti P.C., Aldinger K.A., Fry B., Fan J.B., Schaffner S.F., Waggoner S.G., Tahl A.R., Sklar P. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol. Psychiatry 2010, 15:810-815.
27. Pivac N., Kim B., Nedic G., Joo Y.H., Kozaric-Kovacic D., Hong J.P., Muck-Seler D. Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croat. Med. J. 2009, 50:43-48.
28. Qin L., Kim E., Ratan R., Lee F.S., Cho S. Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression. J. Neurosci. 2011, 31:775-783.
29. Riemenschneider M., Schwarz S., Wagenpfeil S., Diehl J., Müller U., Förstl H., Kurz A. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E e4 allele. Mol. Psychiatry 2002, 7:782-785.
30. Sharma H.S. Neurotrophic factors attenuate microvascular permeability disturbances and axonal injury following trauma to the rat spinal cord. Acta Neurochir. Suppl. 2003, 86:383-388.
31. Sharma H.S., Nyberg F., Westman J., Alm P., Gordh T., Lindholm D. Brain derived neurotrophic factor and insulin like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord. An immunohistochemical study in the rat. Amino Acids 1998, 14:121-129.
32. Shimizu E., Hashimoto K., Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. J. Genet. B. Neuropsychiatr. Genet. 2004, 126B:122-123.
33. Siironen J., Juvela S., Kanarek K., Vilkki J., Hernesniem J., Lasppalainien J. The Met allele of BDNF Val66Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:2858-2860.
34. Szczepankiewicz A., Skibinska M., Czerski P.M., Kapelski P., Leszczynska-Rodziewicz A., Slopien A., Dmitrzak-Weglarz M., Rybakowski F., Rybakowski J., Hauser J. No association of the brain-derived neurotrophic factor (BDNF) gene C-270T polymorphism with schizophrenia. Schizophr. Res. 2005, 187-193.
35. Van Swieten J.C., Kuodstaal P.J., Visser M.C. Intraobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
36. Vermeij F.H., Scholte op Reimer W.J., de Man P., van Oostenbrugge R.J., Franke C.L., de Jong G., de Kort P.L., Dippel D.W. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc. Dis. 2009, 27:465-471. Netherlands Stroke Survey Investigators.
37. Weimar C., Roth M.P., Zillessen G. Complications following acute ischemic stroke. Eur. Neurol. 2002, 48:133-140.
38. Wong K.S. Risk factors for early death in acute ischemic stroke and intracerebral hemorrhages. Stroke 1990, 30:2326-2330.
39. Zhang Y., Toumilehto J., Jousilahti P., Wang Y., Antikainen R., Hu G. Lifestyle factors on the risk of ischemic and hemorrhagic stroke. Arch. Intern. Med. 2011, 171:468-469.